Based on the OPTIMIZERx Corp stock forecast from 8 analysts, the average analyst target price for OPTIMIZERx Corp is USD 9.84 over the next 12 months. OPTIMIZERx Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of OPTIMIZERx Corp is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, OPTIMIZERx Corp’s stock price was USD 8.29. OPTIMIZERx Corp’s stock price has changed by -0.48% over the past week, +81.00% over the past month and -26.90% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for OPTIMIZERx Corp
No recent average analyst rating found for OPTIMIZERx Corp
Company Overview OPTIMIZERx Corp
OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts. Read Less
OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audience...Read More
Frequently Asked Questions About OPTIMIZERx Corp (OPRX) Stock
Based on ratings from 8 analysts OPTIMIZERx Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 13 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on OPRX's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for OPRX is USD 9.84 over the next 12 months. The maximum analyst target price is USD 16 while the minimum anlayst target price is USD 5.
OPRX stock's Price/Earning ratio is 1,306.50.
Our analysis grades OPRX stock's Price / Earning ratio at F. This means that OPRX stock's Price/Earning ratio is above 96% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this OPRX may be a overvalued for its sector.
The last closing price of OPRX's stock was USD 8.29.
The most recent market capitalization for OPRX is USD 0.14B.
Based on targets from 8 analysts, the average taret price for OPRX is projected at USD 9.84 over the next 12 months.
This means that OPRX's stock price may go up by +18.74% over the next 12 months.
We can't find any ETFs which contains OPTIMIZERx Corp's stock.
As per our most recent records OPTIMIZERx Corp has 128 Employees.
OPTIMIZERx Corp's registered address is 260 Charles Street, Waltham, MA, United States, 02453.
You can get more information about it from OPTIMIZERx Corp's website at https://www.optimizerx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About OPTIMIZERx Corp (OPRX) Stock
Based on ratings from 8 analysts OPTIMIZERx Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 13 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on OPRX's stock to indicate if its a good dividend stock.
Based on targets from 8 analysts, the average taret price for OPRX is USD 9.84 over the next 12 months. The maximum analyst target price is USD 16 while the minimum anlayst target price is USD 5.
OPRX stock's Price/Earning ratio is 1,306.50.
Our analysis grades OPRX stock's Price / Earning ratio at F. This means that OPRX stock's Price/Earning ratio is above 96% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this OPRX may be a overvalued for its sector.
The last closing price of OPRX's stock was USD 8.29.
The most recent market capitalization for OPRX is USD 0.14B.
Based on targets from 8 analysts, the average taret price for OPRX is projected at USD 9.84 over the next 12 months.
This means that OPRX's stock price may go up by +18.74% over the next 12 months.
We can't find any ETFs which contains OPTIMIZERx Corp's stock.
As per our most recent records OPTIMIZERx Corp has 128 Employees.
OPTIMIZERx Corp's registered address is 260 Charles Street, Waltham, MA, United States, 02453.
You can get more information about it from OPTIMIZERx Corp's website at https://www.optimizerx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OPRX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
